Skip to main content
Vyome Holdings, Inc logo

Vyome Holdings, Inc — Investor Relations & Filings

Ticker · HIND ISIN · US67424L2097 US Manufacturing
Open in API
Filings indexed 590 across all filing types
Latest filing 2025-09-02 Regulatory Filings
Country US United States of America
Listing US HIND

About Vyome Holdings, Inc

https://www.reshapelifesciences.com/oba…

Vyome Holdings, Inc. is a clinical-stage biotechnology company focused on developing a portfolio of assets for immuno-inflammatory and potential orphan diseases. The company utilizes an artificial intelligence (AI)-driven platform to accelerate its research and development pipeline. Its operations are structured to leverage innovation and R&D capabilities across both the United States and India.

Recent filings

Filing Released Lang Actions
8-K Filing
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, which is used for reporting unscheduled material events or corporate changes. The text references a merger completion and provides financial statements and management discussion for the quarter ended June 30, 2025, as exhibits. However, the main body of the document is an announcement of these events and the filing of related exhibits, not the full financial report itself. The document length is just over 5,000 characters but primarily serves as a notification of the merger and the filing of financial statements as exhibits. According to the rules, such a document is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement and does not contain the full financial report or detailed financial data itself, but rather references and attaches them as exhibits.
2025-09-02 English
8-K Filing
Regulatory Filings Classification · 100% confidence The document is a Form 8-K filed with the SEC by Vyome Holdings, Inc. dated August 18, 2025. It reports on two main items: (1) Entry into a Material Definitive Agreement related to an amendment to an Equity Distribution Agreement increasing the amount of shares to be sold in an at-the-market offering, and (2) a change in the company's independent registered public accounting firm, including details about the dismissal of the previous auditor and appointment of a new auditor. The Form 8-K is a current report used to announce major events that shareholders should know about, including material agreements and auditor changes. It is not an annual or quarterly report, nor a financial statement or earnings release. It is also not a proxy statement, legal proceeding, or other specialized filing. Therefore, the appropriate classification is Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings like Form 8-K that do not fit other specific categories.
2025-08-20 English
424B5 Filing
Capital/Financing Update Classification · 95% confidence The document is a prospectus supplement filed pursuant to Rule 424(b)(5) related to a registration statement on Form S-3. It discusses the offering, issuance, and sale of common stock, including details about the equity distribution agreement, sales agent compensation, and market value of outstanding shares. This type of document is a capital raising update and financing activity announcement rather than a full financial report or earnings release. It does not contain financial statements or management discussion but focuses on the terms and conditions of a securities offering. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is 5656 characters, which is consistent with a detailed supplement rather than a brief announcement or a full annual/interim report.
2025-08-20 English
8-K Filing
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report pursuant to the Securities Exchange Act of 1934. It details the completion of a merger, asset sale, unregistered sales of equity securities, a reverse stock split, changes in the board of directors and senior management, and amendments to the articles of incorporation. The content includes announcements of corporate events, management changes, and capital structure changes rather than comprehensive financial statements or detailed financial analysis. The presence of multiple items such as Item 2.01 (Completion of Acquisition or Disposition of Assets), Item 3.02 (Unregistered Sales of Equity Securities), Item 3.03 (Material Modification of Rights of Security Holders), and Item 5.02 (Departure and Appointment of Directors and Officers) indicates this is a regulatory announcement of significant corporate events. This aligns with the category of Regulatory Filings (RNS), which is the fallback for miscellaneous filings that do not fit other specific categories. The document is not an Annual Report, Earnings Release, or Management Report, nor is it solely a Board/Management Information announcement since it covers multiple event types. Therefore, the best classification is Regulatory Filings (RNS).
2025-08-19 English
SCHEDULE 13G/A Filing
Major Shareholding Notification
2025-08-14 English
10-Q Filing
Interim / Quarterly Report Q2 2025
2025-08-14 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.